Birdwatch Note
2023-09-26 03:40:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Article from 2020. Article states "Hydroxychloroquine should only be used for COVID-19 in a hospital or during clinical trials." Hydroxychloroquine has no efficacy to treat or prevent COVID-19 based on randomized controlled trials. Its use is not recommended by NIH https://www.covid19treatmentguidelines.nih.gov/overview/prevention-of-sars-cov-2/ https://www.sciencedirect.com/science/article/pii/S1477893921001769 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013587.pub2/full https://web.archive.org/web/20200522121119/https://www.mayoclinic.org/drugs-supplements/hydroxychloroquine-oral-route/description/drg-20064216
Written by F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1706108167677940114
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1706514010441388084
- noteId - 1706514010441388084
- participantId -
- noteAuthorParticipantId - F735563C1D6CACAE98B239A5BF3B6B29334E5A32093D655B66C4A4A96408409D Participant Details
- createdAtMillis - 1695699620246
- tweetId - 1706108167677940114
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Article from 2020. Article states "Hydroxychloroquine should only be used for COVID-19 in a hospital or during clinical trials." Hydroxychloroquine has no efficacy to treat or prevent COVID-19 based on randomized controlled trials. Its use is not recommended by NIH https://www.covid19treatmentguidelines.nih.gov/overview/prevention-of-sars-cov-2/ https://www.sciencedirect.com/science/article/pii/S1477893921001769 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013587.pub2/full https://web.archive.org/web/20200522121119/https://www.mayoclinic.org/drugs-supplements/hydroxychloroquine-oral-route/description/drg-20064216
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-09-26 03:40:20 UTC (1695699620246) |
1969-12-31 23:59:59 UTC (-1) |
2023-09-27 02:10:44 UTC (1695780644563) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-09-26 14:59:00 -0500 | Rating Details | |
| 2023-09-26 13:52:45 -0500 | Rating Details | |
| 2023-09-26 13:12:16 -0500 | Rating Details | |
| 2023-09-26 12:59:37 -0500 | Rating Details | |
| 2023-09-26 12:03:20 -0500 | Rating Details | |
| 2023-09-26 11:48:13 -0500 | Rating Details | |
| 2023-09-26 10:56:29 -0500 | Rating Details | |
| 2023-09-26 10:14:45 -0500 | Rating Details | |
| 2023-09-26 10:12:10 -0500 | Rating Details | |
| 2023-09-26 09:14:54 -0500 | Rating Details | |
| 2023-09-26 06:34:50 -0500 | Rating Details | |
| 2023-09-26 06:31:11 -0500 | Rating Details | |
| 2023-09-26 05:07:47 -0500 | Rating Details | |
| 2023-09-26 04:42:54 -0500 | Rating Details | |
| 2023-09-26 04:30:03 -0500 | Rating Details | |
| 2023-09-26 04:07:34 -0500 | Rating Details | |
| 2023-09-26 03:12:16 -0500 | Rating Details | |
| 2023-09-26 03:04:59 -0500 | Rating Details | |
| 2023-09-26 02:27:56 -0500 | Rating Details | |
| 2023-09-26 02:03:00 -0500 | Rating Details | |
| 2023-09-26 01:28:38 -0500 | Rating Details | |
| 2023-09-26 00:50:08 -0500 | Rating Details | |
| 2023-09-26 00:23:14 -0500 | Rating Details | |
| 2023-09-25 23:08:45 -0500 | Rating Details | |
| 2023-09-27 19:18:20 -0500 | Rating Details | |
| 2023-09-27 15:15:06 -0500 | Rating Details | |
| 2023-09-27 10:03:18 -0500 | Rating Details | |
| 2023-09-27 08:40:37 -0500 | Rating Details | |
| 2023-09-27 08:06:32 -0500 | Rating Details | |
| 2023-09-27 06:44:54 -0500 | Rating Details | |
| 2023-09-27 06:34:22 -0500 | Rating Details | |
| 2023-09-27 03:31:32 -0500 | Rating Details | |
| 2023-09-27 00:16:21 -0500 | Rating Details | |
| 2023-09-26 22:09:21 -0500 | Rating Details | |
| 2023-09-26 20:34:36 -0500 | Rating Details | |
| 2023-09-26 20:21:59 -0500 | Rating Details | |
| 2023-09-26 20:09:15 -0500 | Rating Details | |
| 2023-09-26 19:55:53 -0500 | Rating Details | |
| 2023-09-26 19:46:49 -0500 | Rating Details | |
| 2023-09-29 11:56:32 -0500 | Rating Details | |
| 2023-10-01 09:13:02 -0500 | Rating Details | |
| 2023-10-03 18:32:28 -0500 | Rating Details | |
| 2023-10-03 03:28:18 -0500 | Rating Details | |
| 2023-10-05 18:40:13 -0500 | Rating Details | |
| 2023-10-11 16:21:11 -0500 | Rating Details | |
| 2024-01-22 09:31:50 -0600 | Rating Details |